| Literature DB >> 954013 |
L H Baker, V K Vaitkevicius, E Gehan.
Abstract
The Southwest Oncology Group has confirmed the superiority of 5-fluorouracil (5-FU) and methyl-CCNU versus 5-FU weekly as treatment for patients with advanced gastrointestinal cancers. The drug combination produced a PR rate of 29.3% compared to the single-drug arm rate of 10.6%; however, the two-drug arm produced much more toxicity. Despite the improved response rate no improvement in survival was observed.Entities:
Mesh:
Substances:
Year: 1976 PMID: 954013
Source DB: PubMed Journal: Cancer Treat Rep ISSN: 0361-5960